| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.049 | 0.8 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |